Month: August 2021

Carson City, NV, Aug. 03, 2021 (GLOBE NEWSWIRE) — Franklin Mining CEO William Petty (OTC Pink: FMNJ) and the Cooperativa Minera Las Piedras, a Bolivian Mining Co-op, have reached an agreement and signed a Letter of Intent outlining the future development plans of the area known as San Ramon. The Las Piedras hold the mining rights for a 62 Cuadricula Concession (nearly 4,000 acres) with indications of heavy mineralization. This region is located within the Precambrian Shield, a geological area rich in Gold, Wolfram, Tantalite, and other minerals located near the town of San Ramon, in the Department of Santa Cruz, Bolivia. Within the Letter of Intent, both parties have expressed their interest in signing a Contract for the Provision of Services for Mining Operation, or an Associative Entrepreneurship, which are different forms of...

BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive Officer and Simon Harford, Chief Financial Officer, will present at the 2021 Wedbush PacGrow Virtual Healthcare Conference on Tuesday, August 10, at 3:30 p.m. ET. The live webcast of the presentation will be accessible from the Media & Investors page of Albireo’s website, ir.albireopharma.com. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of the webcasts will be available for replay in the Events & Presentations section of the Media & Investors page of Albireo’s website for 30 days following the event. About...

WOBURN, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its second quarter 2021 financial results and provide a corporate update on Wednesday, August 11, 2021. Management will host a conference call on Wednesday, August 11, 2021 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following management’s formal remarks, there will be a question and answer session. To listen to the conference call, interested parties within the U.S. should call 1-877-709-8150. International callers should call +1-201-689-8354. The call will also be available through a live webcast and will reference a slide deck, both of which may be accessed through the investor relations section...

Bonum Bank Plc Stock Exchange Release 3 August 2021 at 15.30 Bonum Bank Plc: Bonum Bank’s credit ratings affirmed with stable outlook Rating agency S&P Global Ratings has affirmed the ‘BBB/A-2’ long-term and short-term issuer credit ratings of Bonum Bank Plc. The outlook remains stable.   The S&P release is enclosed in pdf-format and it is also published in www.poppankki.fi. The previous S&P release was published in January 2021. Further information: CEO Pia Ali-Tolppa, Bonum Bank Plc, Tel: +358 50 303 1476, email: pia.ali-tolppa@poppankki.fi CEO Pekka Lemettinen, POP Bank Centre coop, Tel: +358 40 503 5411, email: pekka.lemettinen@poppankki.fi   Distribution: Nasdaq Helsinki Main media www.poppankki.fi Bonum Bank Plc is the central credit institution of the amalgamation of POP Banks. Bonum Bank obtains external funding...

Initial results demonstrate that AI models of genomic data can predict cancer outcomes. This has the potential to help personalize ovarian cancer treatments and drive the discovery of new therapies. MINNEAPOLIS, Aug. 03, 2021 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is excited to report initial results on AI-driven models of ovarian cancer. POAI subsidiary Helomics, working on data from the 100,000 Genomes Project in Genomics England’s National Genomic Research Library (NGRL), has developed a new AI-driven model that can predict survival rates for ovarian cancer patients, post-treatment. These AI models have the potential to improve treatment paths for ovarian cancer and drive the development...

MINNEAPOLIS, Aug. 03, 2021 (GLOBE NEWSWIRE) — SharpLink Gaming Ltd. (Nasdaq: SBET) (“SharpLink” or the “Company”), a pioneer of game-changing technological solutions and experienced-based services for the U.S. online sports betting industry, today announced that based on revelatory insights and successful results generated by SharpLink’s C4 Sports Betting Conversion Platform (“C4”) launched on NASCAR.com earlier this year, NASCAR is perpetuating and expanding its relationship with SharpLink to provide for multiple new features and betting opportunities to be served to NASCAR fans through the end of the 2021 racing season. For nearly ten years, SharpLink has been a trusted free-to-play game development partner to NASCAR. In February 2021, SharpLink and NASCAR further expanded their longstanding relationship when NASCAR deployed...

The Company’s recent acquisition of A1 Glass Coating will be the springboard to provide glass security solutions across the United States C-Bond to hold investor call today at 2:00 pm EST, to discuss Patriot Glass Solutions, the A1 Glass Coating acquisition and the Company’s strategic direction HOUSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has launched Patriot Glass Solutions to protect personal and business property across the United States. C-Bond’s proprietary glass strengthening technology protects property from looting, rioting, break-ins, and gunfire. With the Company’s recent acquisition of A1 Glass Coating, its premier window film distributor, C-Bond is re-branding its Safety Solutions Group as “Patriot Glass...

PITTSBURGH, Aug. 03, 2021 (GLOBE NEWSWIRE) — L.B. Foster Company (NASDAQ: FSTR), a leading provider of products and services for the rail industry and solutions to support critical infrastructure projects, today reported its 2021 second quarter operating results, which included the following performance highlights:Net sales for the 2021 second quarter were $154.5 million, a $38.4 million sequential increase, or 33.1%, over the first quarter, and a $13.0 million increase, or 9.2%, year-over-year.Gross profit for the 2021 second quarter was $26.2 million, a $7.3 million sequential improvement, or 38.9%, over the first quarter. This year’s second quarter gross profit declined $2.0 million, or 7.0%, from the prior year quarter. The 2021 second quarter gross profit margin was 16.9% versus 19.9% in last year’s comparable...

HOPEWELL JUNCTION, N.Y., Aug. 03, 2021 (GLOBE NEWSWIRE) — eMagin Corporation or the “Company,” (NYSE American: EMAN), a leader in the development, design and manufacture of Active Matrix OLED microdisplays used in Military and Commercial AR/VR devices, and other near-eye imaging products, today announced it will release results for the second quarter on August 12, 2021. Management will host a conference call and simultaneous webcast at 9 a.m. EST on August 12, 2021, to discuss quarterly results, business highlights and outlook. The live, listen-only webcast will be accessible on the Company’s Investor Relations website via https://www.emagin.com/investors/events. A replay of the event will be available approximately one hour after the live event. To join the conference call within the United States, dial (844)-308-1725, for international...

PR for Tues Aug 3Enhanced Tauri-Gum™ Product Line (All 11 SKUs + Rainbow Deluxe Pack)NEW YORK, NY, Aug. 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, has today announced the arrival of product inventory for its enhanced Tauri-Gum™ product line (11 SKUs in Total).  This inventory is available, immediately, on the Company’s E-Commerce website (www.taurigum.com).  Additionally, the Company is focused on the commercial launch (of its Enhanced Tauri-Gum™ Product Line) to the retail marketplace.      ENAHNCED Tauri-Gum™ CHEWING GUM PRODUCT LINE:  SKU # 1): 25mg CBD Mint Flavor SKU # 2): 25mg CBD Blood Orange Flavor SKU # 3): 25mg CBD Pomegranate Flavor SKU # 4): 25mg CBG Black Currant Flavor SKU...